1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
Protean Small Cap
Fee
1.40%
ISIN
SE0020181022
Holdings
24
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with Protean Small Cap, we have 23 holdings where Acast is the largest holding (5.42), followed by Devyser Diagnostics (4.02) and ITAB Shop Concept (3.94).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Protean Small Cap.
| UBS Lux Equity Fund Biotech USD | Protean Small Cap |
|---|---|
|
10.04 % |
 5.42 % |
|
9.21 % |
4.02 % |
 4.66 % |
3.94 % |
|
4.13 % |
 3.65 % |
|
3.75 % |
3.55 % |
| - |
3.43 % |
| - |
3.23 % |
| - |
3.2 % |
| - |
3.04 % |
| - |
3.03 % |
| - |
2.98 % |
| - |
2.96 % |
| - |
2.91 % |
| - |
2.83 % |
| - |
2.82 % |
| - |
 2.61 % |
| - |
 2.5 % |
| - |
2.47 % |
| - |
2.34 % |
| - |
2.06 % |
| - |
1.96 % |
| - |
1.96 % |
| - |
1.79 % |
| - |
1.76 % |
The list of fund holdings was last updated on September 10, 2025.
